Skip to main content
Journal of Family Medicine and Primary Care logoLink to Journal of Family Medicine and Primary Care
. 2024 Jun 28;13(7):2576–2584. doi: 10.4103/jfmpc.jfmpc_1970_23

The impact of COVID-19 on tuberculosis in most populated state of India: A geospatial meta-analysis

Vandana Priyadarshi 1, Shashank Tripathi 2,
PMCID: PMC11272013  PMID: 39071010

ABSTRACT

Background:

Tuberculosis is one of the major burdens to developing nations. India is among the countries categorized by the World Health Organization (WHO) as experiencing a significant burden of TB, HIV-associated TB, and MDR/RR-TB within the context of low- and middle-income nations. Globally South East Asian and African region alone accounted for 82% of death (HIV negative), where India accounts for 36% of TB fatalities.

Materials and Methods:

The data was extracted from NIKSHAY web portal on TB notification cases in UP, India. The random effects meta-analysis was performed to estimate pooled proportion of TB cases in public and private notified during both the periods. Spatial analysis was used to display the spread of TB cases across the state, during both the periods.

Results:

A total 75 districts data on TB notified cases were available for current investigation. The pooled proportion of TB cases were 0.24 (0.21, 0.27) and 0.76 (0.73, 0.79) during COVID-19 period for private and public hospitals, respectively. Similarly, the pooled proportion of TB cases were 0.26 (0.23, 0.29) and 0.74 (0.71, 0.77) post-COVID-19 for private and public hospitals, respectively.

Conclusion:

The proportion of TB cases were more in public hospital as compared to private hospitals during COVID-19 period. Similarly, result was obtained in post-COVID-19 period.

Keywords: COVID-19, infectious diseases, meta-analysis, spatial analysis, tuberculosis

Background

Tuberculosis is the first infectious disease to be identified in history[1] that originates from the genus Mycobacterium.[2] Mycobacterium tuberculosis is the communicable disease that majorly affects pulmonary and extrapulmonary parts of body.[3] The Mycobacterium tuberculosis has exceptionally potent pathogen that has caused morbidity and mortality worldwide, accounting 9.6 million new cases.[4] Tuberculosis spreads through bronchial tree (bronchogenic spread) lymphatics or blood stream, lymph-haematogenous spread and intracanalicular spread (e.g., bronchi to trachea to larynx to gastro intestinal tract). The M. Bacterium mainly induced through inhalation of bacilli containing droplet nuclei and polymorphonuclear granulocytes and alveolar macrophages absorb but it outlives.[5] The risk factors associated with TB infection are patient factor (recipient), pathogens factor and environmental factor.[6] Undernutrition, alcohol use, disorder, smoking, diabetes and HIV are the major causes of getting affected from the infection.[7] The disease recurrently happens more inside the household or within the community, resulting into lopsided spatial patterns over the specific region. The population variation has significant impact on its areal clustering, reflecting continuous transmission and co-location of risk factors for spread of tuberculosis.[8]

Tuberculosis is one of the major burdens to developing nations. Majorly population with TB infection found in low- and middle-income countries.[7] Southeast Asian and African region alone accounts for 82% of death (HIV negative), where India accounts for 36% of TB fatalities. According to WHO there is 8.6% increase in TB related deaths from 2015 to 2020 in Southeast Asian and 6.6% increase in India[9] The infection is significant in the areas with a high proportion of the population, and it can be a challenge with latent TB infection among millions of people which can reoccur at any moment of time.[10]

The spread of COVID-19 became the biggest encounter of 2020, as it has impacted the treatment of tuberculosis patient, its investigation and prevention because of the lockdown.[11] There has been downturn in diagnosis of people with TB during COVID-19 globally from pretrend of 2020.[7] Tuberculosis cases supersede leaving behind the previous reported cases, and there is an increase in the mortality due to Tuberculosis, as there is interruption caused by COVID-19.[12] The TB notification cases as per the daily record from NIKSHAY portal of Health Ministry of India reveals that there is a drastic decrease in the notification of TB cases during COVID outbreak and the period of lockdown.[13] So as to maintain an adequate and consistent high-quality service of healthcare facility, it is essential to address the gap and need of region in combatting the Tuberculosis disease.[14] Efficient strategy to control together with socio-economic development while considering low- and moderate-income countries the disease is still a biggest health crisis yet to be resolved.[15] We did investigation to estimate the pooled prevalence of TB in Uttar Pradesh, notified during and after pandemic, in private and public hospitals simultaneously. Additionally, the significant difference between during and post-COVID-19 period was checked in private and public hospitals separately. Also, the trends in TB reported cases in 75 districts of TB were checked, during and after pandemic separately.

Materials and Methods

Data sources

The data for TB notification cases are collected by the Ministry of Health and Family Welfare NIKSHAY web portal, from the period of lockdown to July 2023 (for Uttar Pradesh). The population density of U.P. district has been collected from Census of India and the availability of doctors per district discussed in relation to notified cases in district acquired from Department of Medical Health and Family Welfare.

Study setting

The selected region for the study is Uttar Pradesh, India. The state is most fertile region and well-irrigated land, attracting high population. UP has the highest number cases of TB. The notification rate per 1,00,000:230 in UP is highest among all the states of India. UP accounts for 7,54,533 doctors and availability of 3,388 Public Hospital Centres with highest number in Prayagraj and lowest in Shrawasti.

Outcome

The proportion of TB cases notified in public hospitals and private hospitals during COVID-19 period and post-COVID-19 period, respectively.

Statistical analysis

We used z-proportion test to check the statistically significant difference between proportions of TB cases in public notified during COVID-19 and public notified post-COVID-19 period, in 75 districts of UP. We used P value <0.05 as a threshold for significance, i.e., if P value is less than 0.05, the result is statistically significant. Similarly, the same test is used to compare the proportions of private notified cases of TB during COVID-19 and private notified cases of TB post-COVID-19 period, of same places. We used the technique of meta-analysis to estimate the pooled proportion of public notified and private notified cases of TB during COVID-19 and post-COVID-19 period separately. The Q-statistic and I2-statistic were used to identify heterogeneity between proportions of TB cases reported by districts of UP. If the degree of heterogeneity in effect size was significantly high (i.e., I2 > 30%), random effect model was used; otherwise, fixed effect model is used.[16]

We constructed forest plots which displayed individual proportions of each district (along with 95% CI) and pooled proportion at the end of graph (along with its 95% CI). We constructed line diagram was to compare the trend between public notified and private notified cases of TB during COVID-19 and post-COVID-19 separately.

We also used Arc GIS to map the spatial distribution of the notified cases in public and private hospitals. Here, dot density has been used for representing proportion of cases during the COVID-19 and post-COVID-19 period (in both public and private). Choropleth method used to show density of population depicted by intensity of colour in district of U.P. giving the clear picture of the expanse of the notification of tuberculosis. The density has been divided into five classes from the very high to very low density of population shown merged with layer of notification of TB cases during the time of COVID-19 and post-COVID-19 period in public and private hospitals in overall Uttar Pradesh.

Results

Trends in TB cases

The trend line [Figure 1a] was made for the TB cases reported in private vs public hospital during COVID-19. The trend line suggests that notified cases of TB were more in public hospitals as compared to private hospitals. Similarly, the trend line [Figure 1b] was made for the TB cases reported in private vs public hospital post-COVID-19. Here, the trend line suggests that notified cases of TB were more in public hospitals as compared to private hospitals.

Figure 1.

Figure 1

Trend lines between private notified patients vs public notified patients of TB (a) during COVID-19 and (b) post-COVID-19

Proportion dissimilarity

We observed significant difference between 65 number of districts of UP, in public hospitals during COVID-19 and post-COVID-19 period, whereas 10 districts of state have shown no significant difference for same period in public hospitals. Similarly, 69 and 06 districts have shown significant difference and no significant difference in proportion of TB cases reported from private hospitals cases before COVID-19 and post-COVID-19. Tables 1 and 2 show the proportions and comparisons of all districts.

Table 1.

Comparison of proportion of TB patient’s public notified during COVID and post-COVID in the districts of Uttar Pradesh

Districts Patients Public Notified (During COVID) (%) Patients Public Notified (Post-COVID) (%) P
Agra 24902 (65.8) 16118 (51.2) <0.05
Aligarh 15836 (65.5) 15110 (67.2) <0.05
Ambedkar Nagar 4585 (71.1) 4424 (75.6) <0.05
Amethi 3690 (89.1) 3138 (82.3) <0.05
Auraiya 3294 (81.6) 3107 (83.4) 0.03
Ayodhya 6925 (81.4) 6441 (68.1) <0.05
Azamgarh 9656 (83.8) 9119 (75.5) <0.05
Baghpat 4244 (79.1) 2972 (71.3) <0.05
Bahraich 8919 (74.1) 8531 (75.1) 0.07
Ballia 6059 (79.5) 5637 (69.9) <0.05
Balrampur 5257 (89.1) 4963 (88.1) 0.08
Banda 4662 (79.9) 3763 (62.2) <0.05
Barabanki 8890 (87.4) 8331 (81.1) <0.05
Bareilly 16562 (55.6) 13504 (57.5) <0.05
Basti 7093 (73.1) 5690 (63.8) <0.05
Bijnor 10143 (80.7) 9033 (63.7) <0.05
Budaun 11048 (88.3) 11263 (90.4) <0.05
Bulandshahar 11511 (76.3) 10410 (71.1) <0.05
Chandauli 4289 (90.8) 3748 (92.1) 0.04
Chitrakoot 2939 (84.3) 2910 (87.5) <0.05
Deoria 5568 (75.1) 5146 (79.1) <0.05
Etah 5054 (60.1) 4752 (61.5) 0.07
Etawah 5825 (79.3) 5353 (82.4) <0.05
Farrukhabad 4668 (73.4) 4536 (80.5) <0.05
Fatehpur 7426 (80.8) 6665 (82.5) <0.05
Firozabad 6565 (72.9) 6711 (66.1) <0.05
Gautam Budh Nagar 9010 (72.9) 8940 (66.1) <0.05
Ghaziabad 19174 (77.7) 15943 (73.3) <0.05
Ghazipur 5208 (87.4) 5278 (87.2) 0.77
Gonda 9233 (91.1) 8037 (76.2) <0.05
Gorakhpur 11841 (57.4) 11783 (60.2) <0.05
Hamirpur 3449 (88.7) 3029 (89.2) 0.52
Hapur 4588 (79.2) 3673 (73.1) <0.05
Hardoi 14177 (91.5) 12424 (80.8) <0.05
Hathras 4088 (77.5) 3394 (75.4) 0.01
Jalaun 3687 (73.3) 3859 (72.6) 0.43
Jaunpur 9407 (72.6) 8529 (75.8) <0.05
Jhansi 4689 (40.9) 4968 (47.3) <0.05
Jyotiba Phule Nagar 3715 (77.2) 3625 (74.9) <0.05
Kannauj 3780 (92.3) 3715 (90.3) <0.05
Kanpur Dehat 4458 (87.9) 3969 (89.4) 0.01
Kanpur Nagar 15914 (47.9) 14836 (52.1) <0.05
Kanshiram Nagar 3952 (68.3) 3924 (73.9) <0.05
Kaushambi 3515 (88.8) 3206 (84.9) <0.05
Kheri 9844 (73.2) 10075 (69.6) <0.05
Kushinagar 5896 (75.6) 5657 (79.3) <0.05
Lalitpur 3245 (54.2) 2560 (52.5) 0.07
Lucknow 22456 (59.1) 22630 (68.6) <0.05
Maharajganj 4837 (87.5) 4203 (83.4) <0.05
Mahoba 1926 (82.2) 2257 (87.6) <0.05
Mainpuri 4460 (88.9) 3867 (85.7) <0.05
Mathura 6892 (28.9) 5413 (26.1) <0.05
Mau 4486 (62.1) 4096 (67.5) <0.05
Meerut 13097 (62.1) 12459 (63.2) 0.01
Mirzapur 6876 (86.5) 5218 (78.3) <0.05
Moradabad 9369 (49.8) 9836 (55.5) <0.05
Muzaffarnagar 9577 (81.4) 7950 (68.3) <0.05
Pilibhit 5792 (75.6) 4654 (73.7) 0.01
Pratapgarh 7142 (91.1) 7182 (86.4) <0.05
Prayagraj 16161 (63.4) 14053 (61.5) <0.05
Rae Bareli 6310 (84.1) 6624 (77.5) <0.05
Rampur 10345 (82.2) 7873 (71.9) <0.05
Saharanpur 13832 (82.4) 11527 (72.1) <0.05
Sambhal 4108 (57.6) 4052 (61.3) <0.05
Sant Kabir Nagar 3791 (83.6) 3372 (84.8) 0.15
Sant Ravidas Nagar 3415 (80.9) 2822 (84.9) <0.05
Shahjahanpur 10062 (70.9) 9006 (68.3) <0.05
Shamli 3447 (71.1) 3663 (77.6) <0.05
SHRAWASTI 2898 (99.1) 2680 (97.9) <0.05
Siddharthnagar 4780 (85.8) 4678 (86.5) 0.31
Sitapur 14982 (63.1) 12877 (66.7) <0.05
Sonbhadra 4997 (82.5) 3978 (85.2) <0.05
Sultanpur 5423 (86.1) 4569 (85.9) 0.81
Unnao 9121 (92.5) 7748 (90.6) <0.05
Varanasi 13830 (60.2) 14535 (67.1) <0.05

Table 2.

Comparison of proportion of TB patients private notified during COVID and post-COVID in the districts of Uttar Pradesh

Districts Patients Private Notified (During COVID) (%) Patients Private Notified (Post-COVID) (%) P
Agra 12920 (34.1) 15335 (48.7) <0.05
Aligarh 8323 (34.4) 7373 (32.7) <0.05
Ambedkar Nagar 1807 (28.2) 1422 (24.3) <0.05
Amethi 454 (10.9) 674 (17.6) <0.05
Auraiya 742 (18.3) 614 (16.5) 0.03
Ayodhya 1574 (18.5) 3022 (31.9) <0.05
Azamgarh 1865 (16.1) 2944 (24.4) <0.05
Baghpat 1120 (20.8) 1192 (28.6) <0.05
Bahraich 3133 (25.9) 2840 (24.9) 0.07
Ballia 1560 (20.4) 2423 (30.1) <0.05
Balrampur 640 (10.8) 670 (11.8) 0.08
Banda 1169 (20.1) 2282 (37.7) <0.05
Barabanki 1276 (12.5) 1937 (18.8) <0.05
Bareilly 13178 (44.3) 9950 (42.4) <0.05
Basti 2621 (26.9) 3225 (36.1) <0.05
Bijnor 2418 (19.2) 5144 (36.2) <0.05
Budaun 1457 (11.6) 1188 (9.5) <0.05
Bulandshahar 3564 (23.6) 4235 (28.9) <0.05
Chandauli 431 (9.1) 322 (7.9) 0.04
Chitrakoot 547 (15.6) 415 (12.4) <0.05
Deoria 1852 (24.9) 1365 (20.9) <0.05
Etah 3350 (39.8) 2974 (38.4) 0.07
Etawah 1518 (20.6) 1137 (17.5) <0.05
Farrukhabad 1687 (26.5) 1092 (19.4) <0.05
Fatehpur 1759 (19.1) 1412 (17.4) <0.05
Firozabad 2429 (27) 3446 (33.9) <0.05
Gautam Budh Nagar 4881 (35.1) 4606 (34) 0.5
Ghaziabad 5492 (22.2) 5782 (26.6) <0.05
Ghazipur 749 (12.5) 772 (12.7) 0.77
Gonda 896 (8.8) 2499 (23.7) <0.05
Gorakhpur 8769 (42.5) 7789 (39.7) <0.05
Hamirpur 437 (11.2) 365 (10.7) 0.52
Hapur 1201 (20.7) 1352 (26.9) <0.05
Hardoi 1307 (8.4) 2951 (19.1) <0.05
Hathras 1183 (22.4) 1102 (24.5) 0.01
Jalaun 1339 (26.6) 1452 (27.3) 0.43
Jaunpur 3537 (27.3) 2714 (24.1) <0.05
Jhansi 6767 (59.1) 5528 (52.6) <0.05
Jyotiba Phule Nagar 1094 (22.7) 1209 (25.1) <0.05
Kannauj 311 (7.6) 396 (9.6) <0.05
Kanpur Dehat 613 (12.1) 468 (10.5) 0.01
Kanpur Nagar 17273 (52.1) 13593 (47.8) <0.05
Kanshiram Nagar 1833 (31.6) 1380 (26.1) <0.05
Kaushambi 441 (11.1) 569 (15.1) <0.05
Kheri 3599 (26.7) 4391 (30.3) <0.05
Kushinagar 1893 (24.3) 1468 (20.6) <0.05
Lalitpur 2732 (45.7) 2313 (47.4) 0.07
Lucknow 15558 (40.9) 10356 (31.3) <0.05
Maharajganj 687 (12.4) 834 (16.5) <0.05
Mahoba 416 (17.7) 317 (12.3) <0.05
Mainpuri 553 (11.1) 643 (14.2) <0.05
Mathura 16954 (71.1) 15280 (73.8) <0.05
Mau 2735 (37.8) 1977 (32.5) <0.05
Meerut 7996 (37.9) 7232 (36.7) 0.01
Mirzapur 1067 (13.4) 1438 (21.6) <0.05
Moradabad 9444 (50.1) 7858 (44.4) <0.05
Muzaffarnagar 2181 (18.5) 3686 (31.6) <0.05
Pilibhit 1867 (24.3) 1656 (26.2) 0.01
Pratapgarh 696 (8.8) 1128 (13.5) <0.05
Prayagraj 9290 (36.5) 8762 (38.4) <0.05
Rae Bareli 1191 (15.8) 1913 (22.4) <0.05
Rampur 2239 (17.7) 3074 (28.1) <0.05
Saharanpur 2938 (17.5) 4466 (27.9) <0.05
Sambhal 3021 (42.3) 2548 (38.6) <0.05
Sant Kabir Nagar 739 (16.3) 603 (15.1) 0.15
Sant Ravidas Nagar 806 (19.1) 501 (15.1) <0.05
Shahjahanpur 4129 (29.1) 4165 (31.6) <0.05
Shamli 1404 (28.9) 1053 (22.3) <0.05
SHRAWASTI 26 (0.8) 57 (2.1) <0.05
Siddharthnagar 785 (14.1) 725 (13.4) 0.31
Sitapur 8729 (36.8) 6419 (33.2) <0.05
Sonbhadra 1058 (17.4) 689 (14.7) <0.05
Sultanpur 870 (13.8) 744 (14.1) 0.81
Unnao 735 (7.4) 800 (9.3) <0.05
Varanasi 9119 (39.7) 7122 (32.8) <0.05

Meta-analysis of TB cases during COVID-19

The heterogeneity between proportion of different districts was statistical significance (P value <05). The I2 obtained for private and public (both) notified cases of TB during COVID-19 period was 100%; therefore, we used random-effects model to estimate the pooled proportion of TB cases during COVID-19. The pooled proportion of TB cases in private notified during COVID-19 was 0.24 with 95% CI 0.21 to 0.27. Similarly, the pooled proportion of TB cases in public notified during COVID-19 was 0.76 with 95% CI 0.73 to 0.79. The forest plots [Figure 2a and b] display the result of current meta-analysis.

Figure 2.

Figure 2

Forest plot for proportion (with 95% CI) of TB patients during COVID-19 in (a) private notified and (b) public notified

Meta-analysis of TB cases post-COVID-19

The heterogeneity between proportion of TB cases for different districts was statistical significance (P value <05). The I2 obtained for private and public (both) notified cases of TB post-COVID-19 period was 100%; therefore, we used random-effects model to estimate the pooled proportion of TB cases post-COVID-19. The pooled proportion of TB cases in private notified post-COVID-19 was 0.26 with 95% CI 0.23 to 0.29. Similarly, the pooled proportion of TB cases in public notified post-COVID-19 was 0.74 with 95% CI 0.71 to 0.7. The forest plots [Figure 3a and b] display the result of current meta-analysis. The detail result is penned in Table 3.

Figure 3.

Figure 3

Forest plot for proportion (with 95% CI) of TB patients post-COVID-19 in (a) private notified and (b) public notified

Table 3.

Pooled proportion of TB cases during and post-COVID-19 by technique of meta-analysis

Hospitals During COVID-19 period Post-COVID-19 period
Public Hospitals 0.76 (0.73, 0.79) 0.74 (0.71, 0.77)
Private Hospitals 0.24 (0.21, 0.77) 0.26 (0.23, 029)

Spatial pattern in public hospitals during COVID-19 vs post-COVID-19 period

The maximum concentration of TB patients could be seen in western and eastern part of U.P. and the concentration of dots spatially fluctuate slightly depicting the increase in the notification in post-COVID-19 period [Figure 4]. Districts in western border and patches around the capital city Lucknow have high dot density, during lockdown. In eastern region, moderate-to-high-density population thrive where high concentration also be found in Sant Ravidas Nagar and Varanasi. While Mahoba, Shrawasti, Chitrakoot, Lalitpur, Auraiya having the lowest cases (during lockdown) count. While in post-COVID-19 Lucknow, Agra, Ghaziabad, Aligarh, Kanpur Nagar with highest number and Mahoba, Lalitpur, Shrawasti, Sant Ravidas Nagar, Chitrakoot, Baghpat having the lower notification.

Figure 4.

Figure 4

Spatial distribution of proportion of TB cases notified in public hospitals

Spatial pattern in private hospitals during COVID-19 vs post-COVID-19 period

The number of cases is comparatively low in private hospitals. The concentration of cases in private hospitals shows more disperse dots density [Figure 5]. Concentration in patches could be seen all over U.P. which include district like Kanpur, Mathura, Lucknow, Bareilly, Agra, Moradabad, Prayagaraj, Varanasi during COVID-19 with higher dot density and Shrawasti, Kannauj, Mahoba, Chandauli, Hamirpur lowest number of cases observed (during lockdown) and similar concentration with slight change could be seen in Agra, Mathura, Lucknow, Kanpur, Bareilly, Prayagraj, Moradabad with a greater number of cases. Whereas in Shrawasti, Mahoba, Chandauli, Hamirpur, Kannauj and Chitrakoot, lowest notification is observed (post-COVID-19 period).

Figure 5.

Figure 5

Spatial distribution of proportion of TB cases notified in private hospitals

Discussion

The trend of TB cases reported during both the period are more in public hospitals as compared to private hospitals. The 65 districts have shown significant difference between proportion of TB cases during COVID-19 and post-COVID-19 period in public hospitals. Similarly, the districts which have shown significant difference between proportion of TB cases during COVID-19 vs post-COVID-19 from private hospitals were 69. The pooled proportion of TB cases during COVID-19 from public hospitals were 0.76 (0.73 to 0.79) and private hospitals were 0.24 (0.21, 0.77). Similarly, the pooled proportion TB cases post-COVID-19 from public hospitals were 0.74 (0.71, 0.77), and private hospitals were 0.26 (0.23, 0.29).

The conjectures to understand the effect of COVID-19 on TB cases are: first, TB is bacterial disease, whereas COVID-19 is viral disease. Both the respective diseases effects lungs (primarily) disturbing the respiratory system of body. The cough, fever and difficulty in breathing are common symptoms in both conditions.[17] Second, the transmission occurs through close contacts with infected persons in both conditions.[18,19] Only symptomatic patients with fertile cough are the main source of TB infection, on other hand symptomatic or asymptomatic patients both can be source of COVID-19.[18,19] Third, incubation period is of 05 days for COVID-19,[20] whereas for TB it is for several month to two years.[21]

Fourth, the lockdown resulting due to COVID-19, to stop community wide spread of COVID-19 may open the door for household transmission for TB. One of the major risk factors for TB is prolong contact at household level.[22] Cillioni et al. 2020[23] predicted for 5 years that 3 months of lockdown has increases 1.65 million TB cases and 438.000 mortality due to TB in India. Fifth, children living with adults infected with TB has shown higher prevalence of TB.[24,25] Household transmission of TB have been increased.[24,25] Sixth, the distribution of routine services to TB patients has increase drastically due to all focus towards COVID-19. The negligence towards TB is due to over coverage or importance to COVID-19 from policymakers. The stress and anxiety have increased drastically in healthcare workers, leading to poor quality care of TB patients. Seventh, the discouragement to people to visit TB centres due to fear created by COVID-19, leading to delay in health services. Late diagnosis and treatment of TB will lead to increase in its transmission and TB programmes will continue facing major problems from late diagnosis and inappropriate treatments. Eight, the seminars, workshops, and annual conferences for exchange of TB research and information were not conducted due to lockdown. The negative effect on BCG vaccination program (for prevention of childhood TB) was observed due to COVID-19.[12] The testing, diagnostic, shortages of resources, etc. for TB programmes and cases of TB are affected negatively due to diversion of forces (like government, public, health professionals, etc.) due to COVID-19. Finally, The COVID-19 causing pneumonia and respiratory failure increases the risk of TB[26] as the respiratory system is damaged for long period. As HIV and influenza (virus-related issues) play important role in spread of TB; hence, it may be inferred COVID-19 may also plays similar role in development of TB.

Managing tuberculosis (TB) while dealing with COVID-19 can be difficult due to the similarities in signs and symptoms between the two diseases. Since SARS-CoV-2 affects the respiratory system, and there is no specific therapy for it, drugs are used to reduce viral load and alleviate inflammation. Corticosteroid therapy (CST) is also used for COVID-19, but it poses a risk of reactivation of latent tuberculosis and secondary infection.[27,28] Both the diseases present with respiratory symptoms like shortness of breath, cough, and chest pain, highlighting the significance of diagnostic testing as COVID patients experience dry cough and TB patients have a productive cough with sputum production, as COVID-19 have a relatively higher proportion of concurrent active pulmonary tuberculosis.[28,29] Kim et al. 2008[30] stated in their paper that COVID causes pneumonia and respiratory failure, and the mortality rate reported in patients with acute respiratory failure.[30]

The major limitations of the current investigation are it has only focused on the single state of India (UP). Hence, further investigation should be performed by including more states of India to get a clear picture on proportion of TB cases during COVID-19 vs post-COVID-19. Also, the current investigation has used descriptive statistics, i.e., it is a descriptive phenomenon. Hence, further investigation must be conducted using statistics like odds ratio (OR) to check the risk of COVID-19 in TB cases. The meta-regression technique was not applied, which can identify a significant predictor effecting the proportion of TB cases during mentioned periods. Hence, the predictors like sex ratio, co-morbidity, etc. should be considered and meta-regression technique should be applied. The subgroup meta-analysis should also be performed by dividing the districts into high and low population density areas, etc. to get a clearer scenario.

Conclusion

The study found significant difference for public notified cases of TB during COVID-19 and post-COVID-19 in various districts of Uttar Pradesh. The pooled proportion of TB cases in private notified during COVID-19 was 0.24 with 95% CI 0.21 to 0.27, while the pooled proportion of TB cases in public notified during COVID-19 was 0.76 with 95% CI 0.73 to 0.79.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  • 1.Leung AN. Pulmonary tuberculosis: The essentials. Radiology. 1999;210:307–22. doi: 10.1148/radiology.210.2.r99ja34307. doi: 10.1148/radiology.210.2.r99ja34307. [DOI] [PubMed] [Google Scholar]
  • 2.Pratt PC. Pathology of tuberculosis. Semin Roentgenol. 1979;14:196–203. doi: 10.1016/0037-198x(79)90006-3. doi: 10.1016/0037-198x(79)90006-3. PMID: 112687. [DOI] [PubMed] [Google Scholar]
  • 3.Natarajan A, Beena PM, Devnikar AV, Mali S. A systemic review on tuberculosis. Indian J Tuberc. 2020;67:295–311. doi: 10.1016/j.ijtb.2020.02.005. doi: 10.1016/j.ijtb.2020.02.005. PMID: 32825856. [DOI] [PubMed] [Google Scholar]
  • 4.Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, et al. Ancient origin and gene mosaicism of the progenitor of mycobacterium tuberculosis. PLoS Pathog. 2005;1:e5. doi: 10.1371/journal.ppat.0010005. doi: 10.1371/journal.ppat.0010005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, et al. The risk of tuberculosis in transplant candidates and recipients: A TBNET consensus statement. Eur Respir J. 2012;40:990–1013. doi: 10.1183/09031936.00000712. doi: 10.1183/09031936.00000712. [DOI] [PubMed] [Google Scholar]
  • 6.Wardani DW, Lazuardi L, Mahendradhata Y, Kusnanto H. Clustered tuberculosis incidence in Bandar Lampung, Indonesia. WHO-SEAJPH. 2014;3:179–85. doi: 10.4103/2224-3151.206734. doi: 10.4103/2224-3151.206734. [DOI] [PubMed] [Google Scholar]
  • 7.World Health Organization & Centers for Disease Control and Prevention. Tuberculosis prevention and care among refugees and other populations in humanitarian settings: an interagency field guide. 2022 [Google Scholar]
  • 8.Ren H, Lu W, Li X, Shen H. Specific urban units identified in tuberculosis epidemic using a geographical detector in Guangzhou, China. Infect Dis Poverty. 2022;11:44. doi: 10.1186/s40249-022-00967-z. doi: 10.1186/s40249-022-00967-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, et al. Improving tuberculosis control through public-private collaboration in India: Literature review. BMJ. 2006;332:574–8. doi: 10.1136/bmj.38738.473252.7C. doi: 10.1136/bmj.38738.473252.7C. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Bardhan M, Hasan MM, Ray I, Sarkar A, Chahal P, Rackimuthu S, et al. Tuberculosis amidst COVID-19 pandemic in India: Unspoken challenges and the way forward. Trop Med Health. 2021;49:84. doi: 10.1186/s41182-021-00377-1. doi: 10.1186/s41182-021-00377-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jain A, Mondal R, Prasad R, Singh K, Ahuja RC. Prevalence of multidrug resistant mycobacterium tuberculosis in Lucknow, Uttar Pradesh. Indian J Med Res. 2008;128:300–6. [PubMed] [Google Scholar]
  • 12.WHO consolidated guidelines on tuberculosis: Module 5: Management of tuberculosis in children and adolescents. Geneva: World Health Organization; 2022. PMID: 35404556. [PubMed] [Google Scholar]
  • 13.Golandaj JA. Insight into the COVID-19 led slow-down in TB notifications in India. Indian J Tuberc. 2021;68:142–5. doi: 10.1016/j.ijtb.2020.12.005. doi: 10.1016/j.ijtb.2020.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ghosh S, Moledina N, Hasan MM, Jain S, Ghosh A. Colossal challenges to healthcare workers combating the second wave of coronavirus disease 2019 (COVID-19) in India. Infect Control Hosp Epidemiol. 2022;43:1302–3. doi: 10.1017/ice.2021.257. doi: 10.1017/ice.2021.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sathiyamoorthy R, Kalaivani M, Aggarwal P, Gupta SK. Prevalence of pulmonary tuberculosis in India: A systematic review and meta-analysis. Lung India. 2020;37:45–52. doi: 10.4103/lungindia.lungindia_181_19. doi: 10.4103/lungindia.lungindia_181_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Asthana A, Agarwal R, Tripathi S. Non-steroidal anti-inflammatory drugs as protective factor in alzheimer's diseases: A systematic review and meta-analysis protocol. Adv Alzheimers Dis. 2023;12:17–28. doi: 10.4236/aad.2023.122002. [Google Scholar]
  • 17.Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–5. doi: 10.1016/j.ijid.2020.03.017. doi: 10.1016/j.ijid.2020.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Del Rio C, Malani PN. COVID-19-New insights on a rapidly changing epidemic. JAMA. 2020;323:1339–40. doi: 10.1001/jama.2020.3072. doi: 10.1001/jama.2020.3072. [DOI] [PubMed] [Google Scholar]
  • 19.Morrison J, Pai M, Hopewell PC. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: A systematic review and meta-analysis. Lancet Infect Dis. 2008;8:359–68. doi: 10.1016/S1473-3099(08)70071-9. doi: 10.1016/S1473-3099(08) 70071-9. [DOI] [PubMed] [Google Scholar]
  • 20.Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) From publicly reported confirmed cases: Estimation and Application. Ann Intern Med. 2020;172:577–82. doi: 10.7326/M20-0504. doi: 10.7326/M20-0504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ. 2018;362:k2738. doi: 10.1136/bmj.k2738. doi: 10.1136/bmj.k2738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Acuña-Villaorduña C, Jones-López EC, Fregona G, Marques-Rodrigues P, Gaeddert M, Geadas C, et al. Intensity of exposure to pulmonary tuberculosis determines risk of tuberculosis infection and disease. Eur Respir J. 2018;51:1701578. doi: 10.1183/13993003.01578-2017. doi: 10.1183/13993003.01578-2017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Cilloni L, Fu H, Vesga JF, Dowdy D, Pretorius C, Ahmedov S, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinicalMedicine. 2020;28:100603. doi: 10.1016/j.eclinm.2020.100603. doi: 10.1016/j.eclinm.2020.100603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Singh M, Mynak ML, Kumar L, Mathew JL, Jindal SK. Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child. 2005;90:624–8. doi: 10.1136/adc.2003.044255. doi: 10.1136/adc.2003.044255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lalor MK, Anderson LF, Hamblion EL, Burkitt A, Davidson JA, Maguire H, et al. Recent household transmission of tuberculosis in England, 2010-2012: Retrospective national cohort study combining epidemiological and molecular strain typing data. BMC Med. 2017;15:105. doi: 10.1186/s12916-017-0864-y. doi: 10.1186/s12916-017-0864-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Singh V, Sharma BB, Patel V. Pulmonary sequelae in a patient recovered from swine flu. Lung India. 2012;29:277–9. doi: 10.4103/0970-2113.99118. doi: 10.4103/0970-2113.99118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gopalaswamy R, Subbian S. Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis. Int J Mol Sci. 2021;22:3773. doi: 10.3390/ijms22073773. doi: 10.3390/ijms22073773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.TB/COVID-19 Global Study Group. Tuberculosis and COVID-19 co-infection: Description of the global cohort. Eur Respir J. 2022;59:2102538. doi: 10.1183/13993003.02538-2021. doi: 10.1183/13993003.02538-2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Aggarwal AN, Agarwal R, Dhooria S, Prasad KT, Sehgal IS, Muthu V. Active pulmonary tuberculosis and coronavirus disease. 2019: A systematic review and meta-analysis. PLoS One. 2021;16:e0259006. doi: 10.1371/journal.pone.0259006. doi: 10.1371/journal.pone.0259006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kim YJ, Pack KM, Jeong E, Na JO, Oh YM, Lee SD, et al. Pulmonary tuberculosis with acute respiratory failure. Eur Respir J. 2008;32:1625–30. doi: 10.1183/09031936.00070907. doi: 10.1183/09031936.00070907. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Family Medicine and Primary Care are provided here courtesy of Wolters Kluwer -- Medknow Publications

RESOURCES